Bio-Matrix Scientific's Dr. O'Neill Sees University of Pittsburgh's
Published Study on Culture Blood-Forming Stem Cells from Human Fat
Tissue as Supporting Near Term Benefits of Banking Adipose (Fat)
Derived Stem Cells
SAN DIEGO--(BUSINESS WIRE)--Jun 27, 2007 - The University ofPittsburgh School of Health Sciences issued the following study andpress release, "Scientists Culture Blood-Forming Stem Cells fromHuman Fat Tissue," June 15, 2007, Science Daily: "Researchers atthe University of Pittsburgh School of Medicine have successfullyisolated and cultured human hematopoietic stem cells from fat, oradipose...
Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07
Teleconference to Answer Questions About TA-65, Their Telomerase
Activator With Proven Age Management Benefits
NEW YORK, June 15, 2007 /PRNewswire/ -- Telomerase ActivationSciences, Inc. (T.A. Sciences) recently announced the results ofthe Pivotal 2005 Anti-Aging Trial of TA-65, the first human trialever to show demonstrated, measurable and positive anti-aging
benefits from a Telomerase Activator. Statistically significantresults were found in those taking TA-65 across several keyconditions of agi...
Further Statistical Analysis of the Recent Phase III trial on Lead
Product M6G Shows Additional Benefits
* Statistically significant reduction in sedation during theearly post-operative period compared to morphine * Statistically significant reduction in nausea in the femalepatient population compared to morphine Cambridge, UK, 8th June 2007 - CeNeS Pharmaceuticals plc (AIM:CEN), the Cambridge based biopharmaceutical company, announcesadditional data from post-hoc analysis of th...
Landmark Study Published in the New England Journal of Medicine
Shows Important Benefits of Eprodisate (KIACTA) Treatment for
Patients with Amyloid A (AA) Amyloidosis
ECUBLENS, SWITZERLAND, June 07, 2007 /PRNewswire-FirstCall/ -Neurochem (International) Limited (Neurochem), a wholly-ownedsubsidiary of Neurochem Inc. , announces that the New EnglandJournal of Medicine (NEJM) published the results of the "EprodisateFor AA Amyloidosis Trial" (EFAAT), recognized as a landmarkclinical trial in the search for a treatment of AA amyloidosis. Theresults of the...
New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory
Properties and Increased Health Benefits
- Bifantis shows ability to limit inflammation in models ofarthritis and Salmonella infection, according to data presented atDigestive Disease Week - WASHINGTON, May 21, 2007 /PRNewswire/ -- The biotechnologycompany Alimentary Health today announced results from two studiesthat demonstrate the anti-inflammatory activity of a naturalprobiotic bacterial strain of human origin, Bifantis(R)(...
Copaxone Treatment over Two Years after Short Term Induction with
Mitoxantrone Provided Sustained Benefits to Active
Relapsing-Remitting Multiple Sclerosis Patients
KANSAS CITY, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data havedemonstrated that relapsing-remitting multiple sclerosis (RRMS)patients treated with COPAXONE(R) (glatiramer acetate injection)following brief immunosuppression with mitoxantrone experienced a90 percent reduction in magnetic resonance imaging (MRI)-monitoreddisease activity compared to their baseline. These
benefits wereachieved...
Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival
Benefits as Mitigator Against Radiation-Induced Damage in Study
Chief Scientist to Present Results at 2007 American Association forCancer Research Annual Meeting CLEVELAND, April 09, 2007 /PRNewswire-FirstCall/ -- ClevelandBioLabs, Inc. , announced today the results of its study ofProtectan CBLB502's efficacy as a mitigator of bothgastrointestinal (GI) and hematopoietic (bone marrow/bloodproduction) radiation-induced damage in non-human primates. The...
Calcium Channel Blocker Adalat GITS Offer Additional Benefits
ACTION-trial shows medical and economic advantages of nifedipineGITS therapy LEVERKUSEN, Germany, March 28, 2007 – Two recentlypublished articles in the Journal of Clinical Epidemiology providefurther evidence that the use of the long-acting calcium channelblocker (CCB) nifedipine GITS (Adalat? GITS) has additional
benefits beyond its blood pressure lowing effec...